EZH2 and H3K27me3 levels are also increased at the E-cadherin gene promoter in prostate and pancreatic cancer cells, resulting in the suppression of E-cadherin and promotion of EMT [53,54]. This evidence concerns the gene CDH1 and familial pancreatic carcinoma.